Bracco Imaging S.P.A. — China drug registrations and re-registration deadlines
48 certificates in the NMPA overseas-manufactured drug database (境外生产药品库), snapshot 2026-06-28. Earliest re-registration deadline: 2027-12-13.
| Approval number | Product | Certificate expires | Re-registration deadline (Art. 82) |
|---|---|---|---|
| 国药准字HJ20140111 | ProHance 钆特醇注射液 | 2028-06-13 | 2027-12-13 |
| 国药准字HJ20140112 | ProHance 钆特醇注射液 | 2028-06-13 | 2027-12-13 |
| 国药准字HJ20140113 | ProHance 钆特醇注射液 | 2028-06-13 | 2027-12-13 |
| 国药准字HJ20140400 | ProHance 钆特醇注射液 | 2028-06-13 | 2027-12-13 |
| 国药准字HJ20140401 | ProHance 钆特醇注射液 | 2028-06-13 | 2027-12-13 |
| 国药准字HJ20140402 | ProHance 钆特醇注射液 | 2028-06-13 | 2027-12-13 |
| 国药准字HJ20140739 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20140740 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20140745 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20140751 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20140752 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20140753 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20140754 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20140755 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20140756 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20150012 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20150013 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20150014 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20150015 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20150056 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20150057 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20150058 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20150059 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20150060 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20150061 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20150062 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20150063 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20150064 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20215004 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20215005 | Iomeron 碘美普尔注射液 | 2028-08-21 | 2028-02-21 |
| 国药准字HJ20140883 | Iopamiro 碘帕醇注射液 | 2030-07-20 | 2030-01-20 |
| 国药准字HJ20140885 | Iopamiro 碘帕醇注射液 | 2030-07-20 | 2030-01-20 |
| 国药准字HJ20140886 | Iopamiro 碘帕醇注射液 | 2030-07-20 | 2030-01-20 |
| 国药准字HJ20140887 | Iopamiro 碘帕醇注射液 | 2030-07-20 | 2030-01-20 |
| 国药准字HJ20140888 | Iopamiro 碘帕醇注射液 | 2030-07-20 | 2030-01-20 |
| 国药准字HJ20140889 | Iopamiro 碘帕醇注射液 | 2030-07-20 | 2030-01-20 |
| 国药准字HJ20140890 | Iopamiro 碘帕醇注射液 | 2030-07-20 | 2030-01-20 |
| 国药准字HJ20140891 | Iopamiro 碘帕醇注射液 | 2030-07-20 | 2030-01-20 |
| 国药准字HJ20150239 | Iopamiro 碘帕醇注射液 | 2030-07-20 | 2030-01-20 |
| 国药准字HJ20150240 | Iopamiro 碘帕醇注射液 | 2030-07-20 | 2030-01-20 |
| 国药准字HJ20150241 | Iopamiro 碘帕醇注射液 | 2030-07-20 | 2030-01-20 |
| 国药准字HJ20150242 | Iopamiro 碘帕醇注射液 | 2030-07-20 | 2030-01-20 |
| 国药准字HJ20140919 | MultiHance 钆贝葡胺注射液 | 2030-12-04 | 2030-06-04 |
| 国药准字HJ20140920 | MultiHance 钆贝葡胺注射液 | 2030-12-04 | 2030-06-04 |
| 国药准字HJ20140921 | MultiHance 钆贝葡胺注射液 | 2030-12-04 | 2030-06-04 |
| 国药准字HJ20140922 | MultiHance 钆贝葡胺注射液 | 2030-12-04 | 2030-06-04 |
| 国药准字HJ20140923 | MultiHance 钆贝葡胺注射液 | 2030-12-04 | 2030-06-04 |
| 国药准字HJ20140924 | MultiHance 钆贝葡胺注射液 | 2030-12-04 | 2030-06-04 |
Under the Provisions for Drug Registration (药品注册管理办法) Art. 82, an application to renew an overseas-manufactured drug registration is filed with the Center for Drug Evaluation no later than 6 months before the certificate expires; the filing line column is that arithmetic applied to the expiry cell. Art. 84(1): a certificate with no application by expiry is not re-registered and is cancelled at expiry. Every figure is taken from the public NMPA database as of 2026-06-28, or computed from it. Registration data changes; the NMPA portal governs. This page states no view on whether any of these products' Domestic Responsible Person (境内责任人) arrangements meet NMPA Announcement No. 137 — that cannot be determined from a public entry.